Clinton: Genomics patents OK

President Clinton today acknowledged his role in crashing genomics stocks in March, and said that private companies should be able to patent their genomics discoveries with specific commercial applications.

Genomics stocks responded strongly, with Celera (CRA) up $41.375 (56 percent) to $115 (nearly

Read the full 437 word article

How to gain access

Continue reading with a
two-week free trial.